The U.S. International Trade Commission (ITC) has issued an order that could potentially bar Apple from importing its Apple Watches. The decision comes after the ITC found that the devices violate the patent rights of medical technology company Masimo.
Specifically, Apple's use of light-based technology for reading blood-oxygen levels infringes on Masimo's rights, according to Bloomberg.
Presidential Review and Possible Appeals Await the Decision
Reuters reported that while the ITC ruling will not have an immediate effect, it now faces review by President Joe Biden's administration. The administration will have 60 days to determine whether to veto the import ban based on policy concerns before it goes into effect.
It is worth noting that presidents rarely veto bans in these circumstances. Additionally, Apple can appeal the ban to the U.S. Court of Appeals for the Federal Circuit after the review period ends.
Masimo Chief Executive Officer Joe Kiani has expressed satisfaction with the ruling, stating that it "sends a powerful message that even the world's largest company is not above the law."
The ITC decision, however, did not specify which models of Apple Watches would be affected by the ban. Masimo's original complaint mentioned that the 2020 Apple Watch Series 6, which introduced blood-oxygen monitoring capabilities, infringed on its patents.
Intellectual Property Fight Between Apple and Masimo
The dispute between Apple and Masimo spans several jurisdictions and began with Masimo accusing Apple of stealing its technology and incorporating it into multiple Apple Watch models. In May, a jury trial on Masimo's allegations in a California federal court ended with a mistrial.
In addition to the ITC case, Apple has separately sued Masimo for patent infringement in federal court in Delaware. Apple claims that Masimo's legal actions are a tactical move to clear the path for its competing smartwatch.
Apple is also involved in a patent dispute with medical technology company AliveCor, which has led to an ITC-issued ban on Apple Watch imports. However, the ban is currently on hold during related proceedings concerning the validity of AliveCor's patents.
According to a company report, Apple's wearables, home, and accessory business, including the Apple Watch, AirPods earbuds, and other products, produced an impressive revenue of $8.28 billion in the third quarter of 2023.
Photo: Sophia Stark/Unsplash


Trump Adviser’s Investment in Thrive Capital Draws Scrutiny Over Federal Contracts
Marvell Stock Rises After Record Q1 FY2027 Earnings Fueled by AI Demand
Mega IPOs Like SpaceX and OpenAI Could Reshape S&P 500 and Nasdaq 100 Portfolios in 2026
JPMorgan Sees Biotech Sector at Turning Point, Upgrades Top Pharma Stocks
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
HP Q2 2026 Earnings Beat Expectations Despite Memory Chip Pressure
DOJ Investigates Group Linked to Reid Hoffman Over E. Jean Carroll Lawsuit Funding
Nvidia and Microsoft to Launch AI-Powered Windows PCs at Computex 2026
Synopsys Q2 FY2026 Earnings Beat Driven by AI and Semiconductor Demand
Dell Raises 2027 Revenue Forecast as AI Server Demand Drives Record Quarterly Results
SoftBank to Invest €75 Billion in France AI Data Center Expansion by 2031
Meta Subscription Push Could Add Billions in Recurring Revenue, Says Rosenblatt
Sable Offshore Wins Key Court Battle Over California Oil Pipeline
Elon Musk Explores Possible Tesla-SpaceX Merger Amid Growing AI Investments
Samsung to Invest $1.5 Billion in Vietnam Semiconductor Testing Plant by 2027
Autodesk Beats Q1 Estimates, Acquires MaintainX for $3.6 Billion 



